Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Inventiva Sa
IVACurrent price
2.57 EUR
+0.09 EUR (+3.63%)
Last closed
2.66 USD
Company
www.inventivapharma.com
ISIN
US46124U1079
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
223 532 912 USD
Yield for 12 month
-31.88 %
1Y
3Y
5Y
10Y
15Y
IVA
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France. Address: 50 rue de Dijon, Daix, France, 21121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+18 626 934 USD
Last Year
+12 980 341 USD
Current Quarter
+17 629 348 USD
Last Quarter
+16 600 854 USD
Current Year
+18 651 447 USD
Last Year
+12 980 341 USD
Current Quarter
+17 034 633 USD
Last Quarter
+16 625 367 USD
Key Figures IVA
1 year
3 years
5 years
10 years
EBITDA
-98 356 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-113.34 %
PEG Ratio
–
Return On Equity TTM
-1642.76 %
Wall Street Target Price
–
Revenue TTM
19 275 000 USD
Book Value
-1.51 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-58.7 %
Dividend Yield
–
Gross Profit TTM
18 814 000 USD
Earnings per share
-2.21 USD
Diluted Eps TTM
-2.21 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics IVA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation IVA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
10.864
Price Sales TTM
11.597
Enterprise Value EBITDA
-1.3445
Price Book MRQ
2.1025
Financials IVA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IVA
For 52 weeks
1.53 USD
4.75 USD
50 Day MA
2.29 USD
Shares Short Prior Month
128 897
200 Day MA
2.98 USD
Short Ratio
1.59
Shares Short
853 441
Short Percent
3.06 %
BeatStart